Dr. Faulhaber begins a two-part session by exploring, “Why bother doing respiratory gating?” and the refinements in PET in “stopping” the motion and seeing the lesion better. He also discusses FDG and how imaging techniques have changed with improvements in hardware, software, and fusion.
CPC-012 Respiratory Gating Techniques[ 13:01 ]Play Now | Download
Dr. Faulhaber explores what information (such as malignancy, grade, or previous treatment/surgery) should be specified when a clinician orders a PET, and what information (such as dose, glucose level, and type of scan) should be returned in the final PET report.
Dr. Faulhaber continues his three-part series on clinical indications by looking at PET imaging of the abdomen and comparing treatment planning pre- and post-PET.
CPC-009 Imaging of Gastrointestinal Malignancies Pt2[ 15:11 ]Play Now | Download
Dr. Faulhaber examines how PET has developed clinically as the approval process of CMS has increased. He begins with a brief review of the value of PET over time and the impact of Fluorine-18 tagged with Glucose as a very powerful imaging agent.
CPC-005 Clinical Indication for PET Approved by CMS[ 15:14 ]Play Now | Download
The initial episodes of Clinical PET Cast have been well received. Upcoming programs will cover such wide-ranging topics as:
Approval Process of CMS
Staging & Restaging
Treatment Planning
Gastrointestinal Malignancies
Respiratory Gating
In the future, I am hoping to expand CPC to include a video podcast companion. Your feedback will help me direct these plans and to guide the current podcast into areas most relevant to our practices. Either leave a voicemail at 216-455-0777 or email clinicalpetcast@gmail.com.
Dr. Faulhaber discusses the concept of quantitation and in particular the Standard Uptake Value or SUV. Clinical PET relies on semi-quantitative methods which are based on the data acquired from the patient, and how that data is corrected for attenuation.
